Hengrui Pharma Repurchases 150,000 A Shares for ESOP at RMB 46.10 Average Price

Bulletin Express10-22

On 22 October 2026, Hengrui Pharma filed a Next Day Disclosure Return with the Hong Kong Stock Exchange, confirming the on-market repurchase of 150,000 A shares on the Shanghai Stock Exchange to fund its A-share Employee Stock Ownership Schemes.

The shares were bought at prices ranging from RMB 45.55 to RMB 46.25 per share, translating to a volume-weighted average cost of approximately RMB 46.10. The aggregate consideration for the transaction amounted to RMB 6.92 million.

Post-transaction, Hengrui Pharma’s issued share capital (excluding treasury shares) fell slightly from 6,366.08 million to 6,365.93 million shares, a marginal reduction of 0.002%. Correspondingly, the company’s treasury share balance increased to 13.07 million shares, while the total issued share count remained unchanged at 6,379.00 million.

The company affirmed that the buyback was duly authorised by its board and executed in full compliance with applicable listing rules and domestic regulations governing share repurchases.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment